Allen NE (1977) Macrolide resistance in Staphylococcus aureus: induction of macrolide-resistant protein synthesis. Antimicrob Agents Chemother 11:661-8. doi: 10.1128/aac.11.4.661
Bajantri B, Venkatram S, Diaz-Fuentes G (2018) Mycoplasma pneumoniae: A Potentially Severe Infection. J Clin Med Res 10:535-544. doi: 10.14740/jocmr3421w
Cao B, Qu JX, Yin YD, Eldere JV (2017) Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J 11:419-429. doi: 10.1111/crj.12379
Dumke R, von Baum H, Lück PC, Jacobs E (2010) Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 16:613-6. doi: 10.1111/j.1469-0691.2009.02968.x
Giedraitienė A, Vitkauskienė A, Naginienė R, Pavilonis A (2011) Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas) 47(3):137-46
Hitchcock CA, Barrett-Bee KJ, Russell NJ (1986) The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J Gen Microbiol 132:2421-31. doi: 10.1099/00221287-132-9-2421
Kohli A, Smriti, Mukhopadhyay K, Rattan A, Prasad R (2002) In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob Agents Chemother 46:1046-52. doi: 10.1128/aac.46.4.1046-1052.2002
Lee H, Yun KW, Lee HJ, Choi EH (2018) Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther 16:23-34. doi: 10.1080/14787210.2018.1414599
Li S, Sun H, Liu F, Zhao H, Zhu B, Lv N (2016) Complete Genome Sequence of the Macrolide-Resistant Mycoplasma pneumoniae Strain C267 in China. Genome Announc 4:e00236-16. doi: 10.1128/genomeA.00236-16
Li SL, Sun HM, Zhu BL, Liu F, Zhao HQ (2017) Whole Genome Analysis Reveals New Insights into Macrolide Resistance in Mycoplasma pneumoniae. Biomed Environ Sci 30:343-350. doi: 10.3967/bes2017.045
Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M (2010) Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 67:355-8. doi: 10.1016/j.diagmicrobio.2010.03.004
Löffler J, Einsele H, Hebart H, Schumacher U, Hrastnik C, Daum G (2000) Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett 185:59-63. doi: 10.1111/j.1574-6968.2000.tb09040.x
Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T (2004) Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 48:4624-30. doi: 10.1128/AAC.48.12.4624-4630.2004
Mukhopadhyay K, Kohli A, Prasad R (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother 46:3695-705. doi: 10.1128/aac.46.12.
Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67(4):593-656. doi: 10.1128/mmbr.67.4.593-656.2003
Pereyre S, Gonzalez P, De Barbeyrac B, Darnige A, Renaudin H, Charron A, Raherison S, Bébéar C, Bébéar CM (2002) Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob Agents Chemother 46:3142-50. doi: 10.1128/aac.46.10.3142-3150.2002
Pereyre S, Goret J, Bébéar (2016) Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. Front Microbiol 7:974. doi: 10.3389/fmicb.2016.00974
Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S (2009) Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 64:52-8. doi: 10.1093/jac/dkp160
Principi N, Esposito S (2013) Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 68:506-11. doi: 10.1093/jac/dks457
Raherison S, Gonzalez P, Renaudin H, Charron A, Bébéar C, Bébéar CM (2002) Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis. Antimicrob Agents Chemother 46:672-9. doi: 10.1128/aac.46.3.672-679.2002
Roberts MC (2004) Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol Biotechnol 28:47-62. doi: 10.1385/MB:28:1:47
Saito T, Hashimoto H, Mitsuhashi S (1969) Drug resistance of staphylococci. Foation of erythromycin-ribosome complex. Decrease in the formation of erythromycin-ribosome complex in erythromycin resistant strains of Staphylococcus aureus. Jpn J Microbiol 13:119-21. doi: 10.1111/j.1348-0421.1969.tb00441.x
Saraya T (2016) The History of Mycoplasma pneumoniae Pneumonia. Front Microbiol 7:364. doi: 10.3389/fmicb.2016.00364
Shimizu M, Saito T, Mitsuhashi S (1970) Macrolide resistance in Staphylococcus aureus. Correlation between spiramycin-binding to ribosomes and inhibition of polypeptide synthesis in cell-free system. Jpn J Microbiol 14:215-9. doi: 10.1111/j.1348-0421.1970.tb00512.x
Spector AA, Yorek MA (1985) Membrane lipid composition and cellular function. J Lipid Res 26:1015-35
Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T (2006) Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 50:709-12. doi: 10.1128/AAC.50.2.709-712.2006.
Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y (2013) Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J 32(3):237-40. doi: 10.1097/INF.0b013e31827aa7bd
Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M, Ono S, Kato A, Fukuda Y, Saito A, Kondo E, Teranishi H, Tanaka Y, Wakabayashi T, Akaike H, Ogita S, Ohno N, Nakano T, Terada K, Ouchi K (2017) Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015. Emerg Infect Dis 23:1703-1706. doi: 10.3201/eid2310.170106
Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, Wiid Svarrer C (2012) Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 17:20073. doi: 10.2807/ese.17.05.20073-en
Waites KB, Talkington DF (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17:697-728, table of contents. doi: 10.1128/CMR.17.4.697-728.2004
Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP (2017) Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev 30:747-809. doi: 10.1128/CMR.00114-16
Weisblum B, Siddhikol C, Lai CJ, Demohn V (1971) Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol 106:835-47. doi: 10.1128/JB.106.3.835-847.1971
Wolff BJ, Thacker WL, Schwartz SB, Winchell JM (2008) Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 52:3542-9. doi: 10.1128/AAC.00582-08
Yang HJ, Song DJ, Shim JY (2017) Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 60:167-174. doi: 10.3345/kjp.2017.60.6.167
Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z (2014) More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 58:1034-8. doi: 10.1128/AAC.01806-133695-3705.2002